An AI-powered platform can advance the processing speed of data from large multi-center clinical trials.
Investigators reviewed DNA methylation patterns and how they can aid in differential diagnoses for patients with lacrimal ...
The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...
The study published in JAMA Ophthalmology – the first epidemiologic study to home in on eye injuries in pickleball – reviewed ...
Explainable artificial intelligence (XAI) can identify clinically significant diabetic retinal neurodegeneration (DRN) on ...
HealthDay News — For cancer survivors, postdiagnosis smoking cessation is associated with improved overall survival, according to a study published in the October issue of the Journal of the National ...
In 2 phase 3 studies, acoltremon 0.003% met primary endpoints, demonstrating statistically significant tear production at day 14.
Investigators conducted a large-scale retrospective cohort study of the prevalence and age of onset of retinal detachment and ...
Investigators reviewed ocular side effects of semaglutide use from a global population-based study across 180 countries.
Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback